Hepatitis C virus infection and substance abuse: Medical management and developing models of integrated care - An introduction

Clinical Infectious Diseases

Volumn 40, Issue SUPPL. 5, 2005, Pages

  Kresina, Thomas F ^a   Khalsa, Jag ^a   Cesari, Helen ^a   Francis, Henry ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; PEGINTERFERON;

COCAINE DEPENDENCE; COMORBIDITY; CONFERENCE PAPER; CRIMINAL JUSTICE; DETOXIFICATION; DRUG DEPENDENCE; EPIDEMIC; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LIVER FIBROSIS; MAINTENANCE THERAPY; MEDICAL RESEARCH; MODEL; PATIENT CARE; PATIENT EDUCATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SUBSTANCE ABUSE; SUPERINFECTION; TREATMENT OUTCOME; CLASSIFICATION; HEALTH CARE DELIVERY; INTEGRATED HEALTH CARE SYSTEM; MENTAL DISEASE; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; RISK FACTOR;

COMORBIDITY; DELIVERY OF HEALTH CARE; DELIVERY OF HEALTH CARE, INTEGRATED; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C; HIV INFECTIONS; HUMANS; MENTAL DISORDERS; MODELS, ORGANIZATIONAL; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 16844386660     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/427438     Document Type: Conference Paper

References (29)

1. Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services. 2002 National survey on drug use and health. Available at: http://www.drugabusestatistics.samhsa.gov. Accessed 18 January 2005.
2. Office of the National Drug Control Policy. 2003 Annual report. The President's national drug control strategy. Available at: http://www. whitehousedrugpolicy.gov/policy. Accessed 18 January 2005.
3. Wagner FA, Anthony JC. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epidemiol 2002; 155:1-8.
4. Sterk CE, Theall KP, Elifson KW. Health care utilization among drug using and non-drug using women. J Urban Health 2002; 79:586-99.
5. Villano CL, Rosenblum, Magura S, Fong C. Improving treatment engagement and outcomes for cocaine-using methadone patients. Am J Drug Alcohol Abuse 2002; 28:213-30.
6. Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions among alcohol and drug treatment patients in an HMO. Arch Intern Med 2003; 163:2511-7.
7. Abram KM, Teplin LA, McClelland GM, Dulcan MK. Comorbid psychiatric disorders in youth in juvenile detention. Arch Gen Psychiatry 2003; 60:1097-108.
8. Allen SA, Spaulding AC, Osei AM, et al. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med 2003; 138:187-90.
9. Strader DB, Wright T, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases. Diagnosis, management and treatment of hepatitis C. Hepatology 2004; 39:1147-71.
10. Sulkowski MS, Thomas DL. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment. Clin Infect Dis 2005; 40(Suppl 5):S263-9 (in this issue).
11. Sterling RK. Role of liver biopsy in the evaluation of hepatitis C infection in HIV coinfection. Clin Infect Dis 2005; 40(Suppl 5):S270-5 (in this issue).
12. Fireman M, Indest DW, Blackwell A, Whitehead AJ, Hauser P. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis 2005; 40(Suppl 5):S286-91 (in this issue).
13. Hagan H, Strauss SM, Astone JM, Des Jarlais DC. Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection. Clin Infect Dis 2005; 40(Suppl 5):S297-303 (in this issue).
14. Strathdee SA, Latka M, Campbell J, et al. Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users. Clin Infect Dis 2005; 40(Suppl 5):S304-12 (in this issue).
15. Edlin BR, Kresina TF, Raymond DB, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40(Suppl 5):S276-85 (in this issue).
16. Sylvestre DL. Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug Alcohol Depend 2002; 67:117-23.
17. Scheft H, Fontenette DC. Psychiatric barriers to readiness for treatment for hepatitis C virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital. Clin Infect Dis 2005; 40(Suppl 5):S292-6 (in this issue).
18. Fleming CA, Tumilty S, Murray JE, Nunes D. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care. Clin Infect Dis 2005; 40(Suppl 5):S349-54 (in this issue).
19. Taylor LE. Delivering care to injection drug users coinfected with HIV and hepatitis C virus. Clin Infect Dis 2005; 40(Suppl 5):S355-61 (in this issue).
20. Flanigan TP, Taylor LE, Mitty JA. Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection. Clin Infect Dis 2005; 40(Suppl 5):S346-8 (in this issue).
21. Sylvestre DL. Treating hepatitis C virus infection in active substance users. Clin Infect Dis 2005; 40(Suppl 5):S321-4 (in this issue).
22. Doab A, Treloar C, Dore GJ. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis 2005; 40(Suppl 5):S313-20 (in this issue).
23. Matthews G, Kronborg IJ, Dore GJ. Treatment for hepatitis C virus infection among current injection drug users in Australia. Clin Infect Dis 2005; 40(Suppl 5):S325-9 (in this issue).
24. Backmund M, Reimer J, Meyer K, Gerlach TJ, Zachoval R. Hepatitis C and injection drug users: prevention, risk factors, and treatment. Clin Infect Dis 2005; 40(Suppl 5):S330-5 (in this issue).
25. Dalgard O. Follow-up studies of treatment for hepatitis C virus infection among injection drug users. Clin Infect Dis 2005; 40(Suppl 5):S336-8 (in this issue).
26. Reimer J, Schulte B, Castells X, et al. Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries. Clin Infect Dis 2005; 40(Suppl 5):S373-8 (in this issue).
27. Litwin AH, Soloway I, Gourevitch MN. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin Infect Dis 2005; 40(Suppl 5):S339-45 (in this issue).
28. Clanon KA, Mueller JJ, Harank M. Integrating treatment for hepatitis C virus infection into an HIV clinic. Clin Infect Dis 2005; 40(Suppl 5):S362-6 (in this issue).
29. Boutwell AE, Allen SA, Rich JD. Opportunities to address the hepatitis C epidemic in the correctional setting. Clin Infect Dis 2005; 40(Suppl 5):S367-72 (in this issue).